Halper Sadeh LLC Investigates Fairness of TCBK, ESI, CRNX, SOLS Deals

Corporate Action
โดย GlobeNewswire·Read original
Summary · why it matters

Halper Sadeh LLC, an investor rights law firm, is investigating whether the proposed sales of TriCo Bancshares, Element Solutions, Crinetics Pharmaceuticals, and Solstice Advanced Materials are obtaining fair deals for their shareholders. The firm is examining TriCo Bancshares' sale to First Hawaiian for 2.095 First Hawaiian shares per TriCo share, with TriCo shareholders expected to own approximately 35% of the combined company. It is also reviewing Element Solutions' sale to Solstice Advanced Materials for $10.00 in cash and 0.500 shares of Solstice common stock per Element share, leaving Element shareholders with about 44% of the combined company. Additionally, the investigation covers Crinetics Pharmaceuticals' sale to Vertex Pharmaceuticals for $85.00 per share in cash, and Solstice Advanced Materials' merger with Element Solutions. Halper Sadeh LLC may seek increased consideration, additional disclosures, or other relief on behalf of shareholders.

Impact on stocks 6

Biotech & Genomic Medicine▲ · 2 stocks
Crinetics Pharmaceuticals Inc
CRNX
± MixedCapitalrelevance

Investigation into fairness of Crinetics' sale to Vertex; may seek increased consideration or additional disclosures.

Financials▲ · 2 stocks
TriCo Bancshares
TCBK
± MixedCapitalrelevance

Investigation into fairness of TriCo Bancshares' sale to First Hawaiian; may seek increased consideration or additional disclosures.

Semiconductors▲ · 1 stocks
Element Solutions Inc
ESI
± MixedCapitalrelevance

Investigation into fairness of Element Solutions' sale to Solstice; may seek increased consideration or additional disclosures.

Critical Materials & Supply Chain▲ · 1 stocks
Solstice Advanced Materials, Inc
SOLS
± MixedCapitalrelevance

Investigation into fairness of Solstice's merger with Element Solutions; may seek increased consideration or additional disclosures.

© 2026 MarketDXNews